Problematic Variation in Local Institutional Review of a Multicenter Genetic Epidemiology Study
Authors:
- Julie Hoover-FongJHJulie Hoover-Fong
- Ada HamoshAHAda Hamosh
- Suzanne BeckSBSuzanne Beck
- Terri BeatyTBTerri Beaty
- Garry CuttingGCGarry Cutting
- 16 July 2003
- journal article
- review article
- Published by American Medical Association (AMA) in JAMA
- Vol. 290 (3) , 360-366
Abstract
Research from JAMA — Problematic Variation in Local Institutional Review of a Multicenter Genetic Epidemiology Study — ContextSequencing of the human genome provides an immense resource for studies correlating DNA variation and epidemiology. However, appropriately powered genetic epidemiology studies often require recruitment from multiple sites.ObjectivesTo document the burden imposed by review of multicenter studies and to determine the variability among local institutional review boards (IRBs) in the approval of a multicenter genetic epidemiology study.DesignA PubMed search was performed to determine the frequency of citations of multicenter studies by 5-year intervals from 1974 through 2002. A 7-question survey was sent to all participating study centers to obtain information on frequency of IRB meetings, dates for submission and approval, use/nonuse of a specific consent form, type of review performed, types of consent forms required, preparation time, and number of changes requested by the IRB at each center. Centers also provided a copy of all consent forms they generated and IRB correspondence regarding the study.Setting and ParticipantsThirty-one of 42 cystic fibrosis care centers in this single US multicenter genetic epidemiology study of cystic fibrosis replied, yielding a 74% response rate.Main Outcome MeasuresFrequency of published research studies and consistency among IRBs.ResultsThe number of all published single-center studies has increased 1.3-fold since 1985, while the number of published epidemiology and genetic epidemiology multicenter studies increased by 8- and 9-fold, respectively, during this same period. Evaluation of the risk of the same genetic epidemiology study by 31 IRBs ranged from minimal to high, resulting in 7 expedited reviews (23%) and 24 full reviews (77%). The number of consents required by the IRBs ranged from 1 to 4; 15 IRBs (48%) required 2 or more consents, while 10 (32%) did not require assent for children. The most common concern (52%) of IRBs pertained to the genetic aspects of the study.ConclusionsReview of a protocol for a multicenter genetic epidemiology study by local IRBs was highly variable. Lack of uniformity in the review process creates uneven human subjects protection and incurs considerable inefficiency. The need for reform, such as the proposed centralized review, is underscored by the ever increasing rate of genetic discoveries facilitated by the Human Genome Project and the unprecedented opportunity to assess the relevance of genetic variation to public health.Keywords
This publication has 11 references indexed in Scilit:
- Improving Protection for Research SubjectsNew England Journal of Medicine, 2002
- A Central Institutional Review Board for Multi-Institutional TrialsNew England Journal of Medicine, 2002
- Informed Consent for Population-Based Research Involving GeneticsJAMA, 2001
- Variation in Institutional Review Board Responses to a Standard Protocol for a Multicenter Clinical TrialAcademic Emergency Medicine, 2001
- Monitoring and Ensuring Safety During Clinical ResearchJAMA, 2001
- Human Genomics Research: New Challenges for Research EthicsPerspectives in Biology and Medicine, 2001
- Experts Wrestle With Social, Ethical Implications of Human Genome ResearchJAMA, 2001
- Variability among institutional review boards’ decisions within the context of a multicenter trialCritical Care Medicine, 2001
- The case for a new system for oversight of research on human subjectsJournal of Medical Ethics, 2000
- Rethinking Risks to Human Subjects in Genetic ResearchThe American Journal of Human Genetics, 1998